Overview: Varicella Zoster IgG TestIntroduction: The Varicella Zoster IgG Test detects VZV IgG to confirm immunity to chickenpox or shingles, preventing rash. Aligned with 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding vaccination, treatment planning, and improving outcomes in immunology for patients with suspected VZV exposure.
Other Names: VZV IgG Assay, Chickenpox Immunity Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: VZV IgG testing began in the 1980s with viral immunity research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects VZV IgG to confirm immunity to chickenpox or shingles, guides vaccination, and prevents rash.
Test Parameters: 1. VZV IgG Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of chickenpox, shingles, or vaccination.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document rash, history of chickenpox, shingles, or VZV vaccination. Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, VZV immunity implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect VZV IgG antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for immunity assessment.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Vaccination may cause false positives.
Clinical Significance: Positive VZV IgG confirms immunity, guiding vaccination or antiviral prophylaxis. Negative results may indicate susceptibility, requiring vaccination.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and vaccination planning.
Additional Supporting Tests: VZV IgM, PCR, or clinical evaluation to assess current infection or immunity status.
Test Limitations: Non-specific for active infection; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC VZV Guidelines, 2023; Clinical Infectious Diseases, Marin M, 2022.
